SUMMARY
Current anaesthetic practice devotes considerable attention to preservation of myocardial function and avoidance of ischaemia. To achieve this objective, there must be predictable control of systemic arterial pressure and a stable cardiac rhythm during all phases of anaesthesia. Any new general anaesthetic agent should exhibit these properties before gaining widespread acceptance, especially for patients with ischaemic heart disease.
Desflurane, a new fluorinated methylethyl ether, closely resembles isoflurane in structure. Animal and human studies [1^1] have shown that it consistently decreases systemic arterial pressures, usually doserelated, accompanied by reduced systemic vascular resistance (SVR) . No change in heart rate (HR) with end-tidal concentrations of 0.83 MAC (6 %) was reported in normocapnic young human volunteers, but a progressive increase in HR was noted with 1.24 and 1.66 MAC [1] . A study in human volunteers noted no change in HR during anaesthesia with 5.4% end-tidal desflurane [2] . The effects on cardiac index (CI) were variable with no change after increasing depth of anaesthesia up to 1.66 MAC in humans [1] . In pigs, cardiac output (CO) was unchanged by 0.8 MAC and then decreased progressively with 1.2 and 1.6 MAC [3] . Warltier and Pagel [4] concluded in their review of animal and human studies that the cardiorespiratory effects of desflurane are similar to isoflurane but there may be better control of systemic arterial pressure during stressful stimuli in humans. There may also be less depression of myocardial contractility than occurs with other halogenated anaesdietic agents in humans. These preliminary investigations indicate that desflurane could have a useful role in anaesthesia for patients with coronary artery disease because of its ability to achieve rapid control of circulatory responses and limit myocardial stress and ischaemia [5] With this in mind, we undertook a randomized open-label investigation of the cardiovascular responses of patients undergoing coronary artery R. S. PARSONS, M.A., B.M., B.CH., F.R.C.A., Department of Anaesthetics, UMDS (Guy's Hospital), St Thomas' Street, London bypass surgery comparing an inhaled anaesthetic technique based on desflurane and oxygen with that of a standard i.v. technique using fentanyl, midazolam and oxygen.
PATIENTS AND METHODS
After obtaining institutional Ethics Committee approval and written informed consent, we studied 51 patients of ASA grade II and III. Patients less than 35 and more than 80 years old and those weighing more than 125 kg were excluded, as were those with pre-existing neurological disease or females of childbearing age. Additional exclusion criteria included patients receiving drugs affecting the central nervous system, those who had been receiving any other trial drugs in the 28 days before surgery, patients whose PCV was less than 25% and those who had an unstable cardiovascular status when considered for surgery or had a left ventricular ejection fraction less than 35 %. The patients were then allocated to the two study groups using random number tables; group F received an i.v. technique based on fentanyl and group D received an inhaled technique based on desflurane.
Laboratory investigations before operation included haemoglobin, PCV and urea and electrolytes; these were compared with values obtained 24 h after surgery. A 12-lead ECG was performed on admission. Drug therapy before operation, including P adrenoceptor blocking agents, calcium antagonists and nitrates, was continued up to the morning of surgery, with the exception of atenolol, which was omitted on the day of surgery. Premedication with morphine O.lmgkg" 1 and hyoscine 6|igkg~' i.m. was given approximately 1 h before entry to the anaesthetic room.
After insertion of a peripheral i.v. cannula under local anaesthesia the patients in both groups received midazolam in 0.5-mg increments, as necessary for sedation, during percutaneous insertion of a radial artery cannula and a pulmonary artery flow-directed, balloon-tipped catheter. Baseline cardiovascular measurements were then made (see below). In group F patients, induction of anaesthesia was performed with fentanyl 50 |ig kg" 1 given over 5-10 min with the patients breathing 100% oxygen; in addition, thiopentone up to 2 mg kg" 1 was administered to ensure rapid loss of consciousness if signs of light anaesthesia appeared before completion of the slow fentanyl infusion. In those patients allocated to receive desflurane (group D patients), anaesthesia was induced with thiopentone 2 mg kg" 1 and slow administration of fentanyl 10 ug kg" 1 over 5 min, with the inspired mixture comprising up to 6% desflurane (~ 1 MAC) in oxygen according to systemic arterial pressure. For the administration of desflurane, an Ohio DM 5000 anaesthesia machine (Ohmeda, Madison, WI, U.S.A.), modified with an electrically heated, temperature controlled, constant pressure vaporizer, was used and the concentration of desflurane measured with a Datex PB254 anaesthesia gas monitor modified for desflurane. Pancuronium 0.1 mgkg" 1 was given when the patients were asleep for control of ventilation and to facilitate tracheal intubation. The lungs were ventilated to maintain an arterial Pco 2 of 4.6-5.3 kPa and endtidal carbon dioxide was monitored at all times except during cardiopulmonary bypass (CPB). Anaesthesia was maintained in group F with additional doses of fentanyl (up to 15 ug kg" 1 in a 30-min period) and midazolam (0.5 mg bolus up to 2.5 mg in 30 min) at the discretion of the responsible anaesthetist. Anaesthesia was maintained in group D using up to 2 MAC (~ 12 %) of end-tidal desflurane in oxygen together with supplementary low-dose fentanyl (< 5 ug kg" 1 ) at the discretion of the anaesthetist. In both groups during CPB, fentanyl, midazolam and pancuronium were administered according to clinical need and desflurane was not administered during CPB.
Systemic arterial pressure and HR were monitored continuously and controlled at 120-70 % of mean arterial pressure (MAP) measured in the ward before operation. An increase in systemic arterial pressure was controlled initially by the administration of increments of fentanyl, midazolam, or both (group F) or increasing the inspired concentration of desflurane (group D) in steps of 30 % MAC up to 2 MAC, each step being 4-8 min duration. If these measures proved inadequate or more rapid control was required than this timing would allow, glyceryl trinitrate (GTN) or sodium nitroprusside (SNP) was infused according to prevailing clinical indications. Tachycardia without other signs of light anaesthesia (sweating, lachrymation, swallowing or movement) was treated with a P adrenoceptor blocking agent (esmolol by infusion or bolus injections of atenolol or practolol).
Systemic hypotension and bradycardia were treated according to circumstances. Alteration of patient posture and i.v. fluid administration was the initial treatment. If this was unsuccessful, then both before and after CPB, inspired concentration of the inhalation agent was decreased and i.v. bolus doses of ephedrine or adrenaline or an infusion of dobutamine were administered at the discretion of the anaesthetist. During CPB, systemic hypotension was treated with ephedrine or phenylephrine; during weaning from CPB the study design permitted administration of calcium chloride for systemic hypotension at the discretion of the anaesthetist. Atropine was administered to increase HR if less than 40 beat min" 1 or if the circulation became compromised. The study design allowed for administration of isoprenaline in the absence of a response to atropine. If ischaemic changes were seen on the ECG, GTN was given by continuous infusion. Any deviation from the study design was timed and noted.
The patients' measured variables included systolic, mean and diastolic systemic and pulmonary artery pressures, HR, lead II and V 5 ECG, central venous and pulmonary capillary wedge pressures, cardiac output measured by a thermodilution technique in triplicate, end-tidal carbon dioxide and desflurane concentration, arterial and venous bloodgas tensions and oximetry, and nasopharyngeal temperature. These variables were measured at Statistical analysis of the data obtained for each event were compared between groups using repeated measures analysis of variance. In addition, analysis of covanance was used to compare the intercept of the slopes of each variable reflecting the effects of time on mean values for each group. Dunnett's test was applied to the values within each group to determine the significance of variation from baseline awake values. The groups were compared for each event using 95 % confidence intervals for unpaired samples. Where appropriate, continuity adjusted chi-square tests or Fisher's exact tests were applied to categorical data in the groups. All statistical calculations were performed using the SAS statistical software programs (version 6.04, SAS Institute Inc, Cary, NC, U.S.A.).
RESULTS
Only essential data are presented. Full tabulation of data are available on request from the author.
We studied 51 consecutive patients (26 desflurane, 25 fentanyl) with one patient in group D eliminated during surgery because of equipment failure; thus there were 25 patients in each group for whom complete recordings were available (table I). The two groups were similar in all aspects except for haemoglobin concentration before operation; the difference was 0.8 g/100 ml. There were 21 males in group F and 20 males in group D. Drug therapy before operation was similar in each group. In group F, nitrates were administered to 19 patients, P adrenoceptor blocking agents to 13 patients and calcium antagonists to 19 patients; equivalent numbers for group D were 15, 17 and 16. There were six patients with a diagnosis of hypertension before operation in group F and seven in group D.
Two patients in group D were undergoing coronary artery bypass surgery for a second time.
Thiopentone was administered in 10 patients from group F during induction of anaesthesia. The dose of midazolam was similar in both groups during the preinduction phase of insertion of intravascular catheters but after induction no midazolam was administered to patients in group D until the CPB period. As anticipated, the dose of fentanyl administered after induction was significantly greater in group F than group D but pancuronium requirements before CPB did not differ significantly between the groups (table II) .
The amount of fentanyl administered during CPB was similar for both groups per patient whereas patients in group D received more midazolam (P = 0.043) than group F. After CPB, group F received more fentanyl (P = 0.001) and more midazolam (P = 0.001) than group D. The use of pancuronium was the same until after CPB when group F patients received significantly more pancuronium than group D (P = 0.02). However, the total dose of pancuronium given to each group was similar for both groups. Before CPB, the end-tidal desflurane concentration, initially 3.1% (SD 1.7%) on induction, varied between 2.6% (1.3%) during skin preparation, 3.7% (1.5%) on incision and 4.6% (1.7%) at sternotomy.
There was no difference between groups in those variables measured in the ward (systemic arterial pressure and HR, table I). The results of measurements made while the patients were awake before induction of anaesthesia until the end of surgery are summarized in tables III and IV and shown in figure  1 . The baseline values obtained before induction showed that the groups were similar (tables III, IV, fig. 1 ). On induction, MAP remained constant in patients in group F but HR increased significantly. In group D, when stable desflurane anaesthesia was established (3.1% end-tidal desflurane), there was no change in HR but MAP decreased significantly.
With similar values of stroke volume index (SVI) in both groups, the greater HR in group F contributed to a significantly greater CI in group F than group D. Left ventricular stroke work index (LVSWI) in group D decreased from baseline and was significantly less than in group F. Systemic vascular resistance index (SVRI) in both groups was un- On laryngoscopy, patients in group F showed no change in haemodynamic variables, except a slight decrease in MPAP and PCWP which abolished the differences with group D noted on induction. In group D there was a small increase in HR which abolished the difference on induction found with group F. During skin preparation both CI in group F and HR in group D decreased slightly to return to baseline values. With these changes in CI and reduced MAP in group D, SVRI for group D became significantly lower than group F during skin preparation and LVSWI in group F decreased to less than baseline levels for the first time.
), cardiac index (CI)) obtained before and during anaesthesia in the fentanyl and desflurane groups. Differences between trial groups determined by repeated measures analysis of variance (RM) and analysis of covariance (AC) {\V < 0.05, ffP < 0.01). Differences within groups from awake values for each time determined by Dunnett's test (*P < 0.05). Events: awake (AW), after induction (AS), after laryngoscopy (LA), during skin preparation (SP), after incision (IN), after sternoiomy (ST), before aortic camtulation (BB), 15 min after termination of bypass (AB) and at end of surgery (ES).
With skin incision and sternotomy, important differences between the groups occurred. In group F, there were significant increases greater than baseline in MAP and SVRI, but HR and CI were unchanged. At sternotomy, the increase in MAP from the ward value was 12.8% (95% confidence interval 7-18.5%, P = 0.001). In group D, HR remained at baseline and MAP returned to baseline levels from the significantly lower values found from induction to skin preparation. Only at sternotomy did an increase in SVRI occur in group D which was similar to SVRI in group F. In group F, MAP exceeded the value in group D at incision and sternotomy by 21.6 and 19.7 mm Hg, respectively (P = 0.001 for both). CI in group D was smaller than group F on incision (ns) and remained constant at this value until the onset of CPB. In group D, the significantly lower MAP value and smaller CI (ns) resulted in a significantly smaller value for LVSWI at incision and sternotomy compared with group F. However, before cannulation of the aorta there were major haemodynamic changes in group F with a reduction in MAP back to baseline values but a sharp decrease in CI, SVI and LVSWI. SVRI increased to values greater than at sternotomy. In group D, MAP was less than baseline but CI, SVI and LVSWI remained at the levels found at incision and sternotomy and were considerably greater than in group F. For all these variables the difference between groups was significant. SVRI in group D was 62 % of that in group F. In both groups HR increased compared with baseline values, in group D for the first time after the start of anaesthesia and in group F, HR was greater than group D.
After bypass, MAP in both groups was less than baseline, as was SVRI in group F. HR in both groups was greater than baseline, with a higher value in group F. In both groups CI reached baseline levels 15 min after CPB but SVI and LVSWI were less than baseline in both groups and remained so until the end of surgery. In group F, CI decreased at the end of surgery and was associated with an increase in SVRI to baseline.
The use of vasoactive drugs varied between groups with GTN, phentolamine or SNP being administered significantly more frequently in group F before, during and after CPB (table V) . At sternotomy, 10 patients in group F were receiving GTN compared with one in group D (P = 0.006, Fisher's exact test). With one exception (a patient in group F received phentolamine alone during CPB) all patients receiving phentolamine or SNP at any time during the study had also received GTN. In addition, the use of p adrenoceptor block was more common in group F before CPB (P = 0.02, Fisher's exact test). The use of vasopressor and inotropic agents was infrequent and similar in both groups at all stages of surgery (table V). In three patients from group F, halothane was administered transiently (< 10 min) before CPB for light anaesthesia producing cardiovascular responses. One patient in group D required one bolus of isoprenaline i.v. because of complete heart block after cessation of CPB.
There were no significant differences in blood-gas data between the groups or in end-tidal carbon dioxide concentrations, except for arterial pH and Pco 2 at the end of induction. At this point, arterial Poo 2 was greater than the baseline value in both groups (P < 0.05 for both variables). In addition, arterial Pco 2 was greater in group F (mean 6.95 (SD 1.0) kPa) than group D (mean difference 0.67 kPa, 95% confidence interval 0.13-1.2, P = 0.016) and arterial pH in group F was lower, as expected. However, at laryngoscopy these differ-, ences between groups had disappeared and did not recur throughout the rest of the study. Nasopharyngeal temperature decreased progressively in both groups until onset of CPB and decreased again at the end of surgery. In group D, nasopharyngeal temperature was significantly lower than group F from laryngoscopy until CPB.
There were no differences between groups in operating time, CPB time, aortic cross-clamp time or duration of stay in the intensive care unit after surgery, or in haemoglobin or potassium values obtained 24 h after surgery. In each group, two patients developed Q waves associated with inversion of T waves in previously normal electrocardiograms, with one patient in group F developing a myocardial infarction, a diagnosis made on clinical grounds. Two patients in group F developed a transient supra ventricular tachycardia before CPB. In no patient in group D was the administration of the agent stopped before or after CPB. Two patients in group D underwent further surgery for bleeding. There were no deaths during the period in hospital and there were no incidences of awareness during anaesthesia.
DISCUSSION
The results of this study show that desflurane, used as the principal agent for maintenance of anaesthesia in premedicated patients, can produce stable haemodynamic status during coronary artery surgery.
Compared with a fentanyl-benzodiazepine i.v. technique, desflurane reduced the need for intervention with vasodilator drugs at times of surgical stress and did not increase the requirement for either vasopressor or inotropic agents. Desflurane anaesthesia produced a decrease in systemic arterial pressures, as described previously for desflurane [1, 6] and for halothane, enflurane and isoflurane [5] . This lasted until the start of surgery when MAP returned to awake values for the duration of incision and sternotomy. HR remained unchanged until just before CPB when it increased slightly to reach a mean of 67 beat min" 1 . The depression of MAP and stability of HR are consistent with previous reports in which end-tidal desflurane concentrations of 2.6% [6] to 6% [1] were administered, but contrast with the tachycardia noted following inspired concentrations of 10.9% [7] and end-tidal concentrations of 9-12% [1] .
In contrast, in this study fentanyl anaesthesia maintained MAP at awake levels following induction and laryngoscopy although HR was elevated significantly at these times. These changes have been noted before with fentanyl and pancuronium [8, 9] , but in our study may also be related to increases in arterial Pco 2 at the end of induction with hand ventilation by mask. This increase in arterial Pco 2 may also have contributed to the higher MPAP after fentanyl anaesthesia compared with desflurane at the end of induction. MPAP did not increase after desflurane anaesthesia at any time, confirming previous results [6] . At laryngoscopy there was no change in MAP or HR from induction values, indicating adequate obtunding of responses, as noted also with desflurane. By incision and sternotomy, HR had decreased to baseline levels but MAP increased to peak at sternotomy with a significantly higher value than seen in patients receiving desflurane.
The early changes in cardiac performance with desfiurane were similar to previous reports using 2.5% [6] or 6% [1] end-tidal desfiurane with an initial decrease in CI (ns), associated with no change in PCWP or CVP but LVSWI was reduced. This suggests a reduction in ventricular work which is not caused by increased afterload as both MAP and SVRI are lower than awake values. Rather, this reduction in work is due to depression of myocardial contractility, as suggested by Weiskopf and colleagues [1] , without depression of CI. During skin preparation the decrease in CI became significant but afterload remained low showing a similar trend to CI in a previous report [6] . Up to onset of CPB, CI did not alter, in contrast with another study which reported an increase in CI at sternotomy to baseline in association with a low MAP and normal SVRI [6] . In comparison, in our study at sternotomy MAP was normal and SVRI was elevated with desflurane, afterload was higher and was associated with a smaller CI. This may be explained by the difference in end-points for the administration of desfiurane with specific end-tidal concentrations used in our study while a specific reduction from preoperative systolic pressures without exceeding 2 MAC was the end-point in the other study [6] . The average end-tidal desflurane concentration used in our study was 4.6 % at sternotomy, compared with 6.1 % in the study of Thomson and colleagues [6] . In group F, CI increased on induction and laryngoscopy (ns) in association with a significant increase in HR and was greater than group D until incision. However, the difference in CI between fentanyl and desflurane was abolished on incision and at sternotomy. SVRI was similar in both groups at sternotomy, its elevation above baseline reflecting the elevated MAP and normal CI in group F and a normal MAP and reduced CI in group D. Repeated measures analysis of variance confirmed that SVRI in group F was greater than group D overall.
Before aortic cannulation there were important changes within and between the study groups from the values at sternotomy. With desflurane MAP decreased to be significantly lower than baseline but CI and CVP were unchanged and SVRI returned to baseline. SVI and LVSWI remained at the reduced levels previously noted in our study. In group F, although the afterload was unchanged from baseline with MAP and CVP at baseline values, CI was reduced substantially compared with baseline and group D. There was a similar reduction in SVI and LVSWI but a steep increase in SVRI greatly exceeding SVRI in group D. For group F this is a reduction in flow-related work (CI decreased) associated with increased SVRI. This carries a significant risk of development of myocardial ischaemia with less work performed for the same oxygen consumption [10] . Moffirt and Sethna [5] emphasized the importance of an appropriate balance of HR, MAP and CI to preserve myocardial oxygenation at times of surgical stress. The explanation for the increased SVRI and myocardial depression in group F before cannulation remains unclear as the clinical picture of MAP at normal levels and mean HR at 82 beat min" 1 does not suggest light anaesthesia. HR was also elevated at this time in group D. In this respect desflurane may have proved to be more successful at preserving myocardial performance (CI, SVI and LVSWI) and oxygenation than the fentanyl-midazolam technique by inducing vasodilatation. The effects of vasodilatation with desflurane before aortic cannulation are shown by Thomson and colleagues [6] . CI was maintained at awake levels when there was deliberate reduction of MAP to 80% of control with an accompanying reduction in SVRI.
In our study the decrease in central temperature from awake until before CPB may also support the existence of a vasodilator effect with desflurane, this decrease being considerably greater in group D than group F. Ebert and Muzi [7] have suggested desflurane may have direct vasodilator properties, noting reduced forearm vascular resistance in the presence of high levels of sympathetic nerve activity and reduced MAP with 10.9% inspired desflurane. This contrasts with the results of Weiskopf and colleagues [1] who failed to show any change in calf muscle blood flow with desflurane. This inconsistency has perhaps already been explained by these workers [1] in relation to another, earlier study [11] . The use of a surface warming device [1] while the volunteers were conscious produced control values for calf muscle blood flow in the conscious state that were three times greater than in the other study [11] and also nearly three times the value in the study of Ebert and Muzi [7] . Thus elevated control values [1] may have disguised any subsequent increase in blood flow caused by the vasodilator properties of desflurane.
Interpretation of the results after bypass must allow for the effects of the analgesic and sedative drugs given to both groups during CPB. Desflurane continued to maintain a hypodynamic circulation with only seven patients needing GTN by infusion immediately after CPB compared with 20 in group F to produce similar MAP, CI and SVRI in both groups. MAP remained less than baseline in both groups until the end of surgery. At the end of surgery, however, CI and SVI had decreased to less than baseline in group F but were maintained with desflurane. SVRI increased to return to baseline in group F.
Before CPB, six other patients in group D received i.v. vasodilators. The study design required increases in desflurane in steps of 30 % MAC, each step lasting a minimum of 4 min. This time limit hindered the aggressive application of large concentrations of desflurane to control significant and prolonged increases in systemic pressure. In this situation the investigators resorted to i.v. GTN for rapid control of systemic pressure. Nevertheless, the use of i.v. vasodilators was less frequent than with fentanyl anaesthesia. During CPB and in the post-CPB period, there was more frequent use of vasodilators in group F than group D. Unexpectedly, there was no greater requirement for fentanyl during CPB in group D than group F. This may be because of the larger dose of midazolam used in group D during CPB compared with group F, which may also account for the lesser requirement for vasodilators in group D during CPB.
It became evident during the early stages of the study that 6 % end-tidal desflurane (~ 1 MAC) was often too large a concentration to use for induction after premedication with morphine and hyoscine and induction supplemented with fentanyl lOugkg"
1 . Before reaching this concentration, we found that MAP often decreased to the lower limit set in the study design. Therefore, we chose to administer a concentration of desflurane which maintained MAP just above the pre-defined lower limit (30 % below ward value) before onset of surgery and increase from this concentration as needed according to the study design. The effect of fentanyl on MAC of desflurane has been described recently by Sebel and colleagues [12] who reported that MAC of desflurane using fentanyl 6 ug kg" 1 was reduced from 6.3 to 2.1%. Therefore, in retrospect our attempts to administer at least 1 MAC at induction of anaesthesia, estimated to be 6 % for patients in the 31-65-yr age group [13] , were likely to induce too deep a state of anaesthesia causing excessive arterial hypotension. In our study an end-tidal concentration of 3.1% (SD 1.67%) desflurane was used on induction which corresponds more closely to 2.1 %, the value of Sebel and colleagues [12] , than to 6%, in our previous information [13] . This shows that we were in fact achieving the objective set in the study design to use a minimum of 1 MAC of desflurane for induction and laryngoscopy by adhering to the limits of the study design for MAP.
For adverse events, we were fortunate to have no hospital mortalities and an unremarkable incidence of ECG changes in both groups. This corresponds with the report of Thomson and colleagues [6] who failed to find increased myocardial ischaemia using desflurane anaesthesia supplemented with fentanyl 10 ug kg" 1 at induction. However, in contrast, Helman and co-workers [14] have suggested that induction of anaesthesia with desflurane was associated with a greater incidence of myocardial ischaemia than sufentanil. But this investigation used an inhalation technique with up to 16.4% end-tidal desflurane during induction (mean 10.2%) after i.v. midazolam, thiopentone and pancuronium. During induction no significant haemodynamic changes occurred in the sufentanil group but with desflurane there were significant increases in HR, MAP and MPAP "despite aggressive attempts at rigorous hemodynamic control". No patient in the sufentanil group had ischaemia on induction. In the desflurane group, the frequency of ischaemic episodes was 9 % using Holter electrocardiography and 15% with precordial echocardiography. However, during maintenance of anaesthesia the risk of myocardial ischaemia was not increased significantly compared with sufentanil "when hemodynamics are well controlled". They commented that desflurane was difficult to administer as the sole agent. The authors used GTN to treat both pulmonary hypertension and ECG abnormalities and this may have confounded the detection and extent of ischaemia. We believe that inhalation induction and maintenance with desflurane (up to 2 MAC) as a sole agent in a population of this age undergoing coronary artery surgery is an unusual technique requiring caution. The large concentrations of desflurane administered may explain the differences between the groups in the study of Helman and colleagues [14] . Ebert and Muzi [7] have shown that induction with desflurane with increasing increments up to 10.9% inspired concentration produces tachycardia, systemic hypertension and increased sympathetic nerve activity. They also suggested that sudden changes in inspired desflurane concentration (7.5% up to 10.9%) produce the same responses but these do not occur with sudden changes of 3.6-7.25 % inspired concentration. They postulate that tachycardia in this situation with 10.9 % end-tidal desflurane may be a reflex response to irritation of the airways with this large concentration of desflurane triggering a sympathetic response.
It is of interest that tachycardia and hypertension did not occur with induction with desflurane in this and other studies [6, 15] using supplementary fentanyl 3-10 ug kg' 1 without large (mean > 6 %) endtidal concentrations of desflurane. There would seem to be an advantage in using opioid supplements, especially in higher risk patients with cardiac diseases. As the MAC of desflurane may be reduced to 2.6% with fentanyl 3 ugkg" 1 in humans [12] , it may be inadvisable in patients with ischaemic heart disease to pursue techniques for major or minor surgery using end-tidal concentrations of the order of 10%, the point at which significant tachycardia, hypotension, or both, has been recorded [1, 7, 14] .
The comments of Moffitt and Sethna [5] on the advantages of different anaesthetic techniques are still relevant to this discussion. They make the point that none of the agents they studied produced satisfactory conditions for haemodynamic stability and avoidance of myocardial ischaemia if used alone. However, a combination of adequate P block with heavy premedication followed by fentanyl and enflurane or halothane was the regimen suggested by these authors for patients with good ventricular function. In this study we have shown that desflurane can control systemic arterial pressures without excessive depression of cardiac output, particularly at times of surgical stress. It is possible that in view of its potency and speed of action desflurane also may prove a useful substitute for enflurane or halothane in these circumstances to maintain controlled hypodynamic circulation.
